The lymphocyte-C-reactive protein ratio as the optimal inflammation-based score in patients with hepatocellular carcinoma underwent TACE

The lymphocyte-C-reactive protein ratio (LCR) is a recently described inflammation-based score, and it remains unclear which is the optimal inflammation-based score among patients with hepatocellular carcinoma (HCC) who underwent transarterial chemoembolization (TACE). A large cohort of HCC patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Liang-He, Wei, Wei, Li, Shao-Hua, Zhang, Yong-Fa, Guo, Rong-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7950222/
https://www.ncbi.nlm.nih.gov/pubmed/33589570
http://dx.doi.org/10.18632/aging.202468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7950222/
https://www.ncbi.nlm.nih.gov/pubmed/33589570
http://dx.doi.org/10.18632/aging.202468

Ejemplares similares